T

Taysha Gene Therapies

71 employees

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Central Nervous System
Molecular Biology
Gene Therapy
Genetics
Life Science

Date founded

2020

Funding rounds raised

Total raised

$150M

from 17 investors over 17 rounds

T

Taysha Gene Therapies raised $150M on August 14, 2023

Investors: RTW Investments, LP, Octagon Capital Advisors, GordonMD Global Investments LP, PBM Capital Group, RA Capital Management, L.P., TCG X, The Invus Group and B Capital Group

T

Taysha Gene Therapies raised $95M on August 5, 2020

Investors: PBM Capital Group, Nolan Capital, Inc., GV, Perceptive Advisors, Sands Capital Management, Octagon Capital and The Invus Group

T

Taysha Gene Therapies raised $30M on April 29, 2020

Investors: PBM Capital Group and Nolan Capital, Inc.

FAQ